The Lotte Strauss Prize

strauss211w1.jpg

The Lotte Strauss Prize recognizes meritorious work by an individual 40 years of age or younger in a subject germane to pediatric pathology and published or accepted for publication during the year immediately preceding the award (i.e., published or accepted for publication in 2024). The winner receives a certificate and a $1000 cash award, and presents their research at the 2025 fall SPP meeting.

 

The application requires submission of:

  1. A copy of the paper as a .pdf file
  2. A letter from the nominee or sponsor (if the nominee is not an SPP member) explaining the nominee’s contribution to the work and the contribution of the paper to the field of pediatric pathology
  3. A copy of the nominee’s curriculum vitae

Please submit the required documents for these awards by Tuesday, December 31, 2024, at 23:59 (PST) to:

Selene Koo, MD, PhD
Awards Director, Research and Awards Committee [email protected]

Lotte Strauss Prize Recipients
Year Name Title Published
1986 Mark I. Greene, MD, PhD Unavailable  
1987 No award given    
1988 No award given    
1989 Hiroyuki Shimada, MD Pathologic features of extraosseous Ewing’s sarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Human Pathology 1988;19:442-453
1990 Paul S. Thorner, MD, PhD Abnormalities of the NCI domain of collagen type IV in GBM in canine hereditary nephritis Kidney International 1989;35:843-850
1991 Beverly Rogers, MD Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol 1990;136:541-548
1992 David Witte, MD Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts. J Cell Biology 1991;115:179-190
1993 Stephen Qualman, MD Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 1992;70: 2005-2012
1994 Poul H Sorensen, MD, PhD A second Ewing’s sarcoma translocation t(21;22), fuses the EWS gene to another ETS-family transcription factor ERG. Nature Genetics 1994;6:146
1995 Monique E DePaepe, MD The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kid Int. 1994;46: 1337-1345
1996 No award given    
1997 Raj Kapur, MD, PhD Abnormal microenvironmental signals underlie intestinal aganglionosis in Dominant megacolon mutant mice. Dev Biol 1996;174:360-369
1998 Brett Casey, MD X-linked situs abnormalities result from mutations in ZIC3 Nature Genetics 1997;17:305-308
1999 No award given    
2000 Anirban Maitra, MD The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 1999; 85(3):741-749.
2001 Rusung Tan, MD Cutting edge: defective natural killer cell activation in X-linked lymphoproliferative disease J Immunol 2000;156:3549
2002 Jean-Christophe Fournet, MD, PhD Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism. Association with a reduction of homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2002;158:2177
2003 Csaba Galambos, MD Defective Pulmonary Development in the Absence of Heparin-Binding Vascular Endothelial Growth Factor Isoforms Am J Respiratory Cell and Mol Biology, 2002;27:194-203.
2004 No award given    
2005 Gail H. Deutsch, MD Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung Development, 2005;132:35-47
2006 David Horst, MD, Dr. Med. Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis Int. J. dev. Biol. 2006;50:47-54
2007 Rene L. Galindo, MD A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR Proc. Natl. Acad. Sci. 2006;103:13439- 13444
2008 Kudakwashe R. Chikwava, MB., ChB Analysis of loss of heterozygosity in single-system and multisystem Langerhan’s cell histiocytosis. Pediatr. Dev. Pathol., 2007;10:18-24
2009 Charles G. Mullighan MBBS(Hons), MSc, MD BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Nature 453: 110-4 2008
2010 Cynthia E. Hawkins, MD Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor ï•¡ and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets J. Clin. Oncol. 28: 1337-1344, 2010
2011 Jefferson Terry, MD PhD Expression of CD133 in synovial sarcoma. Appl Immunohistochem Mol Morphol 18; 159-165, 2010
2012 Kyle Kurek, MD Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome PloS Genetics 2011;7(4):e10020500
2013 Robyn C. Reed, MD Symmetrical peripheral gangrene in four pediatric cardiac surgery patients receiving extracorporeal membrane oxygenation. Ped Dev Path 2012;15:217-225
2014 Benjamin Wilkins, MD P53-mediated biliary defects caused by knockdown of cirhia, the zebrafish homolog of the gene responsible for North American Indian Childhood cirrhosis. PLoS ONE 2013;8(10):e77670
2015 Erin R Rudzinski, MD Myogenin, AP2b, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Am J Surg Pathol 2014;38(5):654-659.
2016 Mariana M Cajaiba, MD Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations Hum Path 2016;48:81-87
2017 Miriam Conces, MD A strategy for Helicobacter Immunohistochemistry utilization in pediatric practice Am J Clin Pathol 2016;145(5): 611- 617
2018 Ruth Ann Luna, PhD Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder Cell Mol Gastroenterol Hepatol. 2017;3(2):218-230
2019 Bonnie Cole, MD Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations Ped Dev Path 2018;21(4):380–388
2020 Jessica Davis, MD Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors Am J Surg Pathol. 2019; 43(4): 435-445
2021 Nya Nelson, MD, PhD Mucinous Cell Clusters in Infantile Congenital Pulmonary Airway Malformations Mimic Adult Mucinous Adenocarcinoma But Are Not Associated With Poor Outcomes When Appropriately Resected Am J Surg Pathol. 2020 Aug;44(8):1118-1129
2022 Jennifer Picarsic, MD, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition  
2023

Charlotte F. Kim, MD Texas Children's Hospital

 Prostatic metaplasia and pilar differentiation in gender-affirming mastectomy specimens  
2024

Nicholas S. Willard, DO, Children's Hospital Colorado

 Integration of single‑nuclei RNA‑sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1‑associated plexiform neurofibromas